The study investigates the feasibility, safety, and effectiveness of a high-intensity exercise programme for patients with hypertrophic cardiomyopathy (HCM). Historically, individuals with HCM were advised to avoid intense physical activity due to concerns about sudden cardiac death. However, recent research suggests that exercise might be safer than previously thought, prompting the need for further investigation.
The study explores the correlation between blood glucose level and early signs of a cardiac disease called aortic valve calcification (AVC) in middle-aged people. AVC is a disease in which calcium deposits in the aortic valve harden the valve, and it may eventually lead to aortic stenosis (AS). Without treatment, the disease is hazardous, as it affects the blood flow from the heart.
The American College of Cardiology and the American Heart Association have recently issued new guidelines for the management of patients with acute coronary syndromes (ACS), such as heart attacks. The guidelines merge earlier recommendations for both forms of ACS—STEMI (severe) and NSTEMI—into one set of guidelines.
The study introduces a novel method of acknowledging the important connection between a pregnant woman’s peri- and post-natal mental health and cardiac health. Doctors in the past have most frequently taken into account body functions like blood pressure and cholesterol when measuring a woman’s cardiovascular health.
A 67-year-old hypertensive diabetic with hyperlipidemia who presented with chest pain, progressive exertional dyspnea, orthopnea, and swelling in both the lower extremities. Initial investigation such as an electrocardiogram and cardiac catheterization excluded acute ischemia but documented nonobstructive coronary disease. Transthoracic echocardiography demonstrated left ventricular hypertrophy, severe systolic dysfunction, and increased filling pressures, suspicious for cardiac amyloidosis.
The American Association of Clinical Endocrinology (AACE) has introduced a new guideline for managing dyslipidemia, which refers to abnormal cholesterol levels. This guideline provides evidence-based recommendations for newer drug therapies and emphasizes patient-centered outcomes, particularly the reduction of cardiovascular disease (CVD) risk. It is intended for adults aged 18 and older who have dyslipidemia or high triglycerides and are already receiving standard treatment but may need additional medications.